
|Articles|April 5, 2011
Generic Drugs, Neuroimaging, Pharmacogenetic Approaches, and More
Author(s)Psychiatric Times Editors
Which neuroimaging technologies uses the motion of water molecules to investigate the microstructure and organization of white matter tracts in the brain? Which pharmacogenetic approaches might be used as a predictor of antipsychotic drug response? These questions and more in this quiz.
Advertisement
Which neuroimaging technologies uses the motion of water molecules to investigate the microstructure and organization of white matter tracts in the brain? Which pharmacogenetic approaches might be used as a predictor of antipsychotic drug response? These questions and more in this quiz.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for Priority Review: Centanafadine for Treatment of ADHD
2
Phase 2 Study Initiated for NBI-1065890 to Treat Tardive Dyskinesia
3
Treating Inflammation to Relieve Depression, Anhedonia
4
International Holocaust Remembrance Day and Our Long Road Trip
5






